Terms: = Lymphoma AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
34 results:
1. A novel subtype based on driver methylation-transcription in lung adenocarcinoma.
Wang X; Xu Z; Zhao S; Song J; Yu Y; Yang H; Hou Y
J Cancer Res Clin Oncol; 2024 May; 150(5):269. PubMed ID: 38777866
[TBL] [Abstract] [Full Text] [Related]
2. CCDC86 promotes the aggressive behavior of nasopharyngeal carcinoma by positively regulating EGFR and activating the PI3K/Akt signaling.
Wang Z; Zhou T; Chen X; Zhu X; Liao B; Liu J; Li S; Tan T; Liu Y
Neoplasma; 2023 Dec; 70(6):761-776. PubMed ID: 38247332
[TBL] [Abstract] [Full Text] [Related]
3. CEBPA facilitates LOXL2 and LOXL3 transcription to promote BCL-2 stability and thus enhances the growth and metastasis of lung carcinoma cells in vitro.
Fan L; Jiang W; Chen C; Gao H; Shi J; Wang D
Exp Cell Res; 2024 Feb; 435(2):113937. PubMed ID: 38242344
[TBL] [Abstract] [Full Text] [Related]
4. Detecting Double Expression Status in Primary Central Nervous System lymphoma Using Multiparametric MRI Based Machine Learning.
Liu G; Zhang X; Zhang N; Xiao H; Chen X; Ma L
J Magn Reson Imaging; 2024 Jan; 59(1):231-239. PubMed ID: 37199225
[TBL] [Abstract] [Full Text] [Related]
5. Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol.
Wang J; Jia WG; Yang LH; Kuang WY; Huang LB; Chen HQ; Wang LN; Zhou DH; Liao N
Hematology; 2023 Dec; 28(1):2171723. PubMed ID: 36752506
[TBL] [Abstract] [Full Text] [Related]
6. Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms.
Jaeger A; Gambheer SMM; Sun X; Chernyakov D; Skorobohatko O; Mack T; Kissel S; Pfeifer D; Zeiser R; Fisch P; Andrieux G; Bräuer-Hartmann D; Bauer M; Schulze S; Follo M; Boerries M; von Bubnoff N; Miething C; Hidalgo JV; Klein C; Weber T; Wickenhauser C; Binder M; Dierks C
Blood; 2023 Jun; 141(23):2824-2840. PubMed ID: 36696631
[TBL] [Abstract] [Full Text] [Related]
7.
Jin Q; Chen Y; Du S; Xu D; Yue J; Cai L; Yuan X
Curr Cancer Drug Targets; 2022; 22(11):919-930. PubMed ID: 35909289
[TBL] [Abstract] [Full Text] [Related]
8. Advances and Challenges in the Investigation of Metastasis in Diffuse Large B-Cell lymphoma.
Chen Y; Jiang L; Liu L; Ruan M; Zhou Z; Yang M; Xia L
Mini Rev Med Chem; 2022; 22(22):2808-2812. PubMed ID: 35593342
[TBL] [Abstract] [Full Text] [Related]
9. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
Front Immunol; 2021; 12():671755. PubMed ID: 34447369
[TBL] [Abstract] [Full Text] [Related]
10. Elevated expression of CDT1 in childhood acute lymphoblastic leukemia promotes cell proliferation, invasion and migration through activation of emt.
Shi HX; Huang SW; Luo WJ; Pan F; Jin HJ; Wei W
J Biol Regul Homeost Agents; 2021 Jul; 35(Special Issue on Internal Medicine n.1):. PubMed ID: 34348833
[TBL] [Abstract] [Full Text] [Related]
11. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
[TBL] [Abstract] [Full Text] [Related]
12. PCAT1 induced by transcription factor YY1 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-216a-3p to up-regulate oncogene BCL3.
Sun D; Zhao Y; Wang W; Guan C; Hu Z; Liu L; Jiang X
Biol Chem; 2021 Jan; 402(2):207-219. PubMed ID: 33544468
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating emt and stemness properties through miR-424-5p/BCL9L axis.
Lu M; Qin X; Zhou Y; Li G; Liu Z; Geng X; Yue H
Cell Death Dis; 2021 Jan; 12(1):72. PubMed ID: 33436545
[TBL] [Abstract] [Full Text] [Related]
14. Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan - a population-based study.
Huang HH; Hsiao FY; Chen HM; Wang CY; Ko BS
Br J Haematol; 2021 Jan; 192(1):110-118. PubMed ID: 33131074
[TBL] [Abstract] [Full Text] [Related]
15. BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.
Yu J; Chen L; Bao Z; Liu Y; Liu G; Li F; Li L
Oncol Rep; 2020 May; 43(5):1630-1640. PubMed ID: 32323819
[TBL] [Abstract] [Full Text] [Related]
16. miR‑574‑5p attenuates proliferation, migration and emt in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.
Zhang KJ; Hu Y; Luo N; Li X; Chen FY; Yuan JQ; Guo L
Int J Oncol; 2020 May; 56(5):1240-1251. PubMed ID: 32319565
[TBL] [Abstract] [Full Text] [Related]
17. NK cell-based therapeutics for lung cancer.
Pockley AG; Vaupel P; Multhoff G
Expert Opin Biol Ther; 2020 Jan; 20(1):23-33. PubMed ID: 31714156
[No Abstract] [Full Text] [Related]
18. MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1.
Xu L; Sun HB; Xu ZN; Han XL; Yin YY; Zheng Y; Zhao Y; Wang ZX
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7978-7988. PubMed ID: 31599423
[TBL] [Abstract] [Full Text] [Related]
19. The Role of SATB1 in Tumour Progression and Metastasis.
Glatzel-Plucińska N; Piotrowska A; Dzięgiel P; Podhorska-Okołów M
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450715
[TBL] [Abstract] [Full Text] [Related]
20. LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1/RNF2 in cholangiocarcinoma.
Li J; Jiang X; Li C; Liu Y; Kang P; Zhong X; Cui Y
J Cell Physiol; 2019 Dec; 234(12):22947-22959. PubMed ID: 31119760
[TBL] [Abstract] [Full Text] [Related]
[Next]